How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

A Single Arm, Prospective, Multi-Center Study to Evaluate Safety and Efficacy of Isavuconazole for Primary Treatment of Chinese Patients With Invasive Fungal Disease (IFD) Caused by Aspergillus Species or Other Filamentous Fungi

calendar_today March 20, 2026 person soansm01 domain pfizer

A Single Arm, Prospective, Multi-Center Study to Evaluate Safety and Efficacy of Isavuconazole for Primary Treatment of Chinese Patients With Invasive Fungal Disease (IFD) Caused by Aspergillus Species or Other Filamentous Fungi soansm01 Fri, 03/20/2026 - 06:01 Cresemba® Isavuconazonium Sulfate PHASE IV Tue, 02/07/2023 - 12:00 Fri, 04/11/2025 - 12:00 NCT05630976 C3791001 Public Disclosure Synopsis .pdf (138.68 KB) N https://clinicaltrials.gov/study/NCT05630976?term=C3791001&viewType=Card&rank=1 C3791001

open_in_new Read original post